Literature DB >> 15183124

Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells.

Beatrice Chelli1, Annalisa Lena, Renato Vanacore, Eleonora Da Pozzo, Barbara Costa, Leonardo Rossi, Alessandra Salvetti, Fabrizio Scatena, Stefania Ceruti, Maria P Abbracchio, Vittorio Gremigni, Claudia Martini.   

Abstract

The peripheral benzodiazepine receptor (PBR) is a component of a multiprotein complex, located at the contact site between the inner and outer mitochondrial membranes, which constitutes the mitochondrial permeability transition (MPT)-pore. The opening of the MPT-pore, leading to the transmembrane mitochondrial potential (DeltaPsi(m)) dissipation, is a critical event in the mechanism of apoptosis. In the present work, we investigated the ability of the specific PBR ligands, PK 11195 or Ro5-4864, to affect mitochondrial potential and to induce apoptotic cell death in rat C6 glioma cells. Both specific ligands inhibited cell survival in a dose- and time-dependent manner, as assessed by MTS conversion assay, whereas the non-site selective ligand Diazepam or the low-affinity benzodiazepine Clonazepam showed no significant effects. After cell exposure to PK 11195 or Ro5-4864 we evidenced typical alterations of apoptotic cell death such as DNA fragmentation and chromatin condensation assessed by flow cytometric and transmission electron microscopy (TEM) analysis, respectively. Activation of the "effector" caspase-3 confirmed the ability of specific PBR ligands to induce apoptosis. Moreover, PK 11195 and Ro5-4864 induced a decrease of DeltaPsi(m), as evidenced by JC-1 flow cytometry analysis. Our data demonstrate the pro-apoptotic effects of specific PBR ligands on rat C6 glioma cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183124     DOI: 10.1016/j.bcp.2004.03.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

1.  The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress.

Authors:  Joanna Klubo-Gwiezdzinska; Kirk Jensen; Andrew Bauer; Aneeta Patel; John Costello; Kenneth D Burman; Leonard Wartofsky; Matthew J Hardwick; Vasyl V Vasko
Journal:  J Endocrinol       Date:  2012-05-29       Impact factor: 4.286

2.  A novel reporter system for molecular imaging and high-throughput screening of anticancer drugs.

Authors:  Jingping Xie; Chunxia Wang; John Virostko; H Charles Manning; Wellington Pham; Joshua Bauer; John C Gore
Journal:  Chembiochem       Date:  2013-07-24       Impact factor: 3.164

Review 3.  Glioma cell death: cell-cell interactions and signalling networks.

Authors:  H Anne Leaver; Maria Theresa Rizzo; Ian R Whittle
Journal:  Mol Neurobiol       Date:  2010-05-05       Impact factor: 5.590

4.  Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.

Authors:  Eugene Vlodavsky; Jean F Soustiel
Journal:  J Neurooncol       Date:  2006-07-26       Impact factor: 4.130

Review 5.  The role of mitochondria in glioma pathophysiology.

Authors:  Bartlomiej B Ordys; Séverine Launay; Ruth F Deighton; James McCulloch; Ian R Whittle
Journal:  Mol Neurobiol       Date:  2010-04-24       Impact factor: 5.590

6.  PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect.

Authors:  Tiziana Musacchio; Valentino Laquintana; Andrea Latrofa; Giuseppe Trapani; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

7.  Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.

Authors:  Giuseppe La Regina; Ruoli Bai; Whilelmina Maria Rensen; Erica Di Cesare; Antonio Coluccia; Francesco Piscitelli; Valeria Famiglini; Alessia Reggio; Marianna Nalli; Sveva Pelliccia; Eleonora Da Pozzo; Barbara Costa; Ilaria Granata; Amalia Porta; Bruno Maresca; Alessandra Soriani; Maria Luisa Iannitto; Angela Santoni; Junjie Li; Marlein Miranda Cona; Feng Chen; Yicheng Ni; Andrea Brancale; Giulio Dondio; Stefania Vultaggio; Mario Varasi; Ciro Mercurio; Claudia Martini; Ernest Hamel; Patrizia Lavia; Ettore Novellino; Romano Silvestri
Journal:  J Med Chem       Date:  2012-12-27       Impact factor: 7.446

8.  Single-step high-yield radiosynthesis and evaluation of a sensitive 18F-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET.

Authors:  Emmanuelle Briard; Sami S Zoghbi; Fabrice G Siméon; Masao Imaizumi; Jonathan P Gourley; H Umesha Shetty; Shuiyu Lu; Masahiro Fujita; Robert B Innis; Victor W Pike
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

9.  A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A.

Authors:  Tali Fishman-Jacob; Lydia Reznichenko; Moussa B H Youdim; Silvia A Mandel
Journal:  J Biol Chem       Date:  2009-09-11       Impact factor: 5.157

10.  The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions.

Authors:  Omid Sascha Yousefi; Thomas Wilhelm; Karin Maschke-Neuß; Marcel Kuhny; Christian Martin; Gerhard J Molderings; Felix Kratz; Bernd Hildenbrand; Michael Huber
Journal:  Cell Commun Signal       Date:  2013-02-20       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.